Product & Technology Assessment

BioProcess Technology Consultants' extensive experience and industry knowledge combined with our business acumen make us your preferred partner to perform technology assessments that support critical investment decisions with accurate and timely analysis. We routinely work with our clients to gauge the market acceptance of new technologies and understand potential hurdles or risks associated with adaptation of these technologies for biopharmaceutical product development or manufacturing. Our customized analyses are designed to meet your specific needs resulting in clear and easy to understand reports detailing our findings and recommendations and providing you with the valuable input you require.

With our vast network, we are able to reach into organizations, large and small, to speak with key decision makers most familiar with the industrial state of the art and unmet needs, allowing us to provide you with accurate and timely market information that enables you to fully understand risks and opportunities of any investment or acquisition target.

Our in-depth market and technology assessments can assist you to:

  • Determine market trends, unmet needs, and customer acceptance of new or existing discovery, development, and manufacturing technologies
  • Assess the barriers to regulatory acceptance of new approaches or technologies for the manufacture or analysis of biopharmaceuticals
  • Estimate the global capacity for biopharmaceutical manufacturing, identify potential customers for new technology and service offerings, and understand the implications of new technologies on biopharmaceutical manufacturing

We also can evaluate opportunities to acquire or invest in biopharmaceutical products. To support your strategic and financial investment decisions, our due diligence services include the following activities:

  • Critical review and analysis of product development status and regulatory compliance, detailed gap analysis to identify missing or incomplete CMC issues
  • Recommendations for critical next steps for advancing a product candidate to the next stage of development or commercialization
  • Development of appropriate strategies to understand and mitigate regulatory risk associated with new products

Following the acquisition of a product or portfolio of products, we can use our PROMOTE™ service to build a detailed, comprehensive CMC strategy and plan to ensure regulatory compliance, mitigate risk, and meet all the appropriate product quality and process performance objectives necessary for successful product development.